HopeStage
Back to all studies
TerminatedNCT02227563

tDCS & Auditory Hallucinations in Schizophrenia

Device studyAges 18–60Israel
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Listed locations
JerusalemSee all locations and recruitment

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMarch 2014
Recruitment status
Terminated
Enrollment listed in the registry
3
Sponsor
Herzog Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Israel
Age range
From 18 Years to 60 Years
Official registry ID
NCT02227563
Official title
Show the full official title

tDCS & Auditory Hallucinations in Schizophrenia (AVH-SZ)

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Terminated

Jerusalem

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Herzog Hospital, a hospital or academic medical center.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies